Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus

Molecular Neurobiology

Volumn 48, Issue 3, 2013, Pages 581-589

  Scaini, Giselli ^a,b   Mello Santos, Lis Mairá ^a,b   Furlanetto, Camila B ^a,b   Jeremias, Isabela C ^a,b   Mina, Francielle ^a,b   Schuck, Patrícia F ^a   Ferreira, Gustavo C ^a   Kist, Luiza W ^b,c   Pereira, Talita C B ^b,c   Bogo, Maurício R ^b,c   Streck, Emilio L ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina INCT TM   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Branched chain amino acids; Deferoxamine; Maple syrup urine disease; N acetylcysteine; Nerve growth factor

Indexed keywords

ACETYLCYSTEINE; BRANCHED CHAIN AMINO ACID; DEFEROXAMINE; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN CORTEX; BRAIN MATURATION; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; MALE; MAPLE SYRUP URINE DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; REVIEW; THERAPY EFFECT;

AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; ANTIOXIDANTS; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; NEOSTRIATUM; NERVE GROWTH FACTOR; RATS; RATS, WISTAR;

EID: 84887989119     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8447-1     Document Type: Review

References (71)

1. Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1971-2005
2. Mackenzie DY, Woolf LI (1959) Maple syrup urine disease; an inborn error of the metabolism of valine, leucine, and isoleucine associated with gross mental deficiency. Br Med J 1:90-91
3. Schönberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69-75
4. Snyderman SE, Norton PM, Roitman E, Holt LE Jr (1964) Maple syrup urine disease, with particular reference to dietotherapy. Pediatrics 34:454-472
5. Howell RK, Lee M (1963) Influence of a-keto acids on the respiration of brain in vitro. Proc Soc Exp Biol Med 113:660-663
6. Land JM, Mowbray J, Clark JB (1976) Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease. J Neurochem 26:823-830
7. Danner DJ, Elsas LJ (1989) Disorders of branched chain amino acid and keto acid metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 671-692
8. Pilla C, Cardozo RF, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem Res 28:675-679
9. Sgaravati AM, Rosa RB, Schuck PF, Ribeiro CAJ, Wannmacher CMD, Wyse ATS, Dutra-Filho CS, Wajner M (2003) Inhibition of brain energy metabolism by the a-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232-238
10. Ribeiro CA, Sgaravatti AM, Rosa RB, Schuck PF, Grando V, Schmidt AL, Ferreira GC, Perry ML, Dutra-Filho CS, Wajner M (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33:114-124
11. Amaral AU, Leipnitz G, Fernandes CG, Seminotti B, Schuck PF, Wajner M (2010) Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain. Brain Res 1324:75-84
12. de Franceschi ID, Rieger E, Vargas AP, Rojas DB, Campos AG, Rech VC, Feksa LR, Wannmacher CM (2013) Effect of leucine administration to female rats during pregnancy and lactation on oxidative stress and enzymes activities of phosphoryltransfer network in cerebral cortex and hippocampus of the offspring. Neurochem Res 38(3):632-643
13. Bridi R, Araldi J, Sgarbi MB, Testa CG, Durigon K, Wajner M, Dutra-Filho CS (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327-332
14. Bridi R, Latini A, Braun CA, Zorzi GK, Wajner M, Lissi EG, Dutra-Filho CS (2005) Evaluation of the mechanisms involved in leucine induced oxidative damage in cerebral cortex of young rats. Free Radic Res 39:71-79
15. Fontella FU, Gassen E, Pulrolni V, Wannmacher CMD, Klein AB, Wajner M, Dutra-Filho CS (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47-54
16. Barschak AG, Sitta A, Deon M, Olivera MH, Haeser A, Dutra-Filho CS, Wajner M, Vargas CR (2006) Evidence that oxidative stress in increased in plasma from pacients with maple syrup urine disease. Metab Brain Dis 21:279-286
17. Mescka C, Moraes T, Rosa A, Mazzola P, Piccoli B, Jacques C, Dalazen G, Coelho J, Cortes M, Terra M, Regla Vargas C, Dutra-Filho CS (2011) In vivo neuroprotective effect of l-carnitine against oxidative stress in maple syrup urine disease. Metab Brain Dis 26:21-28
18. Mescka CP, Wayhs CA, Vanzin CS, Biancini GB, Guerreiro G, Manfredini V, Souza C, Wajner M, Dutra-Filho CS, Vargas CR (2013) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect. Int J Dev Neurosci 31:21-24
19. Jouvet J, Rustin P, Taylor DL (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919-1932
20. Jouvet P, Kozma M, Mehmet H (2000) Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids. Ann NY Acad Sci 926:116-121
21. Scaini G, de Rochi N, Jeremias IC, Deroza PF, Zugno AI, Pereira TC, Oliveira GM, Kist LW, Bogo MR, Schuck PF, Ferreira GC, Streck EL (2012) Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease. Mol Neurobiol 45:279-286
22. Taketomi T, Kunishita T, Hara A, Mizushima S (1983) Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease. Jpn J Exp Med 53:109-116
23. Tribble D, Shapira R (1983) Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease. Biochem Biophys Res Commun 114:440-446
24. Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: interrelationship between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15:121-135
25. Wajner M, Vargas CR (1999) Reduction of plasma concentrations of large neutral amino acids in patients with maple urine disease during crises. Arch Dis Child 80:579
26. Wajner M, Coelho DM, Barschak AG, Araújo PR, Pires RF, Lulhier FL, Vargas CR (2000) Reduction of large neutral amino acid concentration in plasma and CSF of patients with maple syrup urine disease during crises. J Inherit Metab Dis 23:505-512
27. Araújo P, Wassermann GF, Tallini K, Furlanetto V, Vargas CR, Wannmacher CM, Dutra-Filho CS, Wyse AT, Wajner M (2001) Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38:529-537
28. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237:1154-1162
29. Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Ann Rew Neurosc 24:1217-1281
30. Mobley WC, Rutkowski JL, Tennekoon GI, Buchanan K, Johnston MV (1985) Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science 229:284-287
31. Gnahn H, Hefti F, Heumann R, Schwab ME, Thoenen H (1993) NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Brain Res 285:45-52
32. Korsching S, Heumann R, Thoenen H, Hefti F (1986) Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor (NGF) without change in mRNA(NGF) content. Neurosci Lett 66:175-180
33. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV (1991) High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350:678-683
34. Chao MV, Bothwell MA, Ross AH, Koprowski H, Lanahan AA, Buck CR, Sehgal A (1986) Gene transfer and molecular cloning of the human NGF receptor. Science 232:518-521
35. Knipper M, Leung LS, Zhao D, Rylett RJ (1994) Short-term modulation of glutamatergic synapses in adult rat hippocampus by NGF. NeuroReport 5:2433-2436
36. Ricceri L, Alleva E, Chiarotti F, Calamandrei G (1996) Nerve growth factor affects passive avoidance learning and retention in developing mice. Brain Res Bull 39:219-226
37. Fischer W, Wictorin K, Bjorklund A, Williams LR, Varon S, Gage FH (1987) Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65-68
38. Nabeshima T, Ogawa S, Yamada K, Ishimaru H, Fuji K, Kameyama T, Fukuta T, Takeuchi R, Hayashi K (1991) Memory impairment and morphological changes in rats after continuous infusion of active fragment of anti-nerve growth factor-antibody. Res Commun Chem Pathol Pharmacol 74:141-152
39. Hennigan A, Callaghan CK, Kealy J, Rouine J, Kelly AM (2009) Deficits in LTP and recognition memory in the genetically hypertensive rat are associated with decreased expression of neurotrophic factors and their receptors in the dentate gyrus. Behav Brain Res 197:371-377
40. Gelfo F, Tirassa P, De Bartolo P, Caltagirone C, Petrosini L, Angelucci F (2011) Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease. J Alzheimers Dis 25:213-217
41. Gu H, Long D, Song C, Li X (2009) Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion. Neurosci Lett 453:204-209
42. De Vries N, De Flora S (1993) N-acetylcysteine. J Cell Biochem 17F:270-277
43. Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B, Buyukbese MA (2005) Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. Tohoku J Exp Med 206:131-139
44. Pinho RA, Silveira PCL, Silva LA, Streck EL, Dal-Pizzol F, Moreira JCF (2005) N-acetycysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. Environ Res 99:355-360
45. De Flora S, Cesarone CF, Balansky RM, Albini A, D'Agostini F, Bennicelli C (1995) Chemopreventive properties and mechanisms of N-acetylcysteine: the experimental background. J Cell Biochem 22:33-41
46. Sprong RC, Winkelhuyzen-Janssen AML, Aarsman CJM, van Oirschot JF, Bruggen T, van Asbeck BS (1998) Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. Am J Respir Crit Care Med 157:1283-1293
47. Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F (2004) Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 32:342-349
48. Damiani CR, Benetton CA, Stoffel C, Bardini KC, Cardoso VH, Di Giunta G, Pinho RA, Dal-Pizzol F, Streck EL (2007) Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium. J Gastroenterol Hepatol 22:1846-1851
49. Di-Pietro PB, Dias ML, Scaini G, Burigo M, Constantino L, Machado RA, Dal-Pizzol F, Streck EL (2008) Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration. Neurosci Lett 434:139-143
50. Bridi R, Fontella FU, Pulrolnik V, Braun CA, Zorzi GK, Coelho D, Wajner M, Vargas CR, Dutra-Filho CS (2006) A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies. J Neurosci Methods 155:224-230
51. Lowry OH, Rosebough NG, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Chem Biol 193:265-275
52. Zielke HR, Huang Y, Baab PJ, Collins RM Jr, Zielke CL, Tildon JT (1997) Effect of alpha-ketoisocaproate and leucine on the in vivo oxidation of glutamate and glutamine in the rat brain. Neurochem Res 22:1159-1164
53. Zielke HR, Huang Y, Tildon JT, Zielke CL, Baab PJ (1996) Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: alpha-ketoisocaproate infusion. Dev Neurosc 18:420-425
54. Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, Dutra-Filho CS (2000) Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181:44-49
55. Lim KC, Tyler CM, Lim ST, Giuliano R, Federoff HJ (2007) Proteolytic processing of proNGF is necessary for mature NGF regulated secretion from neurons. Biochem Biophys Res Commun 361:599-604
56. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, Cattaneo A (2005) Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci USA 102:3811-3816
57. Pirondi S, D'Intino G, Gusciglio M, Massella A, Giardino L, Kuteeva E, Ogren SO, Hokfelt T, Calza L (2007) Changes in brain cholinergic markers and spatial learning in old galanin-overexpressing mice. Brain Res 1138:10-20
58. Terry AV Jr, Kutiyanawalla A, Pillai A (2011) Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats. Physiol Behav 102:149-157
59. Conner JM, Franks KM, Titterness AK, Russell K, Merrill DA, Christie BR, Sejnowski TJ, Tuszynski MH (2009) NGF is essential for hippocampal plasticity and learning. J Neurosci 29:10883-10889
60. Zou L, Yuan X, Long Y, Shine HD, Yang K (2002) Improvement of spatial learning and memory after adenovirus-mediated transfer of the nerve growth factor gene to aged rat brain. Hum Gene Ther 13:2173-2184
61. Scaini G, Teodorak BP, Jeremias IC, Morais MO, Mina F, Dominguini D, Pescador B, Comim CM, Schuck PF, Ferreira GC, Quevedo J, Streck EL (2012) Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease. Behav Brain Res 231:92-96
62. Glaser V, Carlini VP, Gabach L, Ghersi M, de Barioglio SR, Ramirez OA, Perez MF, Latini A (2010) The intra-hippocampal leucine administration impairs memory consolidation and LTP generation in rats. Cell Mol Neurobiol 30:1067-1075
63. Mello CF, Feksa L, Brusque AM, Wannmacher CM, Wajner M (1999) Chronic early leucine administration induces behavioral deficits in rats. Life Sci 65:747-755
64. Zhang L, Jope RS (1999) Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells. Neurobiol Aging 20:271-278
65. O'Loghlen A, Pérez-Morgado MI, Salinas M, Martín ME (2006) N-acetyl-cysteine abolishes hydrogen peroxide-induced modification of eukaryotic initiation factor 4 F activity via distinct signalling pathways. Cell Signal 18:21-31
66. Dimon-Gadal S, Gerbaud P, Keryer G, Anderson W, Evain-Brion D, Raynaud F (1998) In vitro effects of oxygen-derived free radicals on type I and type II cAMP-dependent protein kinases. J Biol Chem 273:22833-22840
67. Abel T, Kandel E (1998) Positive and negative regulatory mechanisms that mediate long-term memory storage. Brain Res Rev 26:360-378
68. Sheng M, Thompson MA, Greenberg ME (1991) CREB: a Ca21-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252:1427-1430
69. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147
70. Bonefeld BE, Elfving B, Wegener G (2008) Reference genes for normalization: a study of rat brain tissue. Synapse 62:302-309
71. Yan J, Welsh AM, Bora SH, Snyder EY, Koliatsos VE (2004) Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord. J Comp Neurol 480:101-114